(HealthDay News) — More than 460 employees who were laid off from their jobs at the US Centers for Disease Control and Prevention (CDC) are being rehired, the Associated Press reported last week.

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

Source: Getty Images Results from the CheckMate 816, SACHI, and NeoADAURA trials may inform the treatment of NSCLC. Targeted therapies and immunotherapy can provide benefits when added to chemotherapy ...

Workers at the NIH sent a letter protesting the Trump administration’s cuts to the agency's budget, staff, and research.

The FDA has approved Zusduri (mitomycin intravesical solution) to treat adults with recurrent, low-grade, intermediate-risk NMIBC.

Keytruda (pembrolizumab) is now approved as perioperative treatment for patients with head and neck squamous cell carcinoma.

Sacituzumab govitecan plus pembrolizumab improves outcomes vs chemotherapy plus pembrolizumab in patients with previously ...

The US Food and Drug Administration (FDA) has approved a new tablet formulation of Brukinsa (zanubrutinib), which is expected to replace the current capsule formulation in October 2025. Brukinsa, a ...

The FDA has granted fast track designation to nadunolimab for use in combination with gemcitabine and nab-paclitaxel to treat patients with previously untreated, metastatic PDAC with high IL1RAP ...

The Clinical Advisor spoke with Carlos Gutiérrez, EdD, MMS, PA-C, about the impact of executive orders on LGBTQ+ health care.

The FDA has granted de novo authorization to CLAIRITY BREAST, a platform that uses AI to help predict a woman's risk of breast cancer.

HHS Secretary Robert F. Kennedy Jr has named 8 new members to the CDC’s Advisory Committee on Immunization Practices.